Posts
Medicare Advantage: The Golden Goose with Hidden Costs?
There’s a lot to love about Medicare Advantage if you’re a beneficiary, plan issuer, or corporation in the MA market. Beneficiaries get some extra benefits like dental coverage while insurers and corporations reap massive revenues from MA payments. Despite its stellar enrollment growth, MA—capturing 51% of the entire Medicare population—is fundamentally broken and costing the…
Read More10 Takeaways From Finovate
Finovate Fall, one of my low-key favorite fintech events, was this week, and in keeping with the established tradition here at Fintech Takes, I would like to share 10 takeaways that I had from the conference. Ready? Here we go. 1.) Fintech Is Boring! I had the pleasure of presenting at Finovate this year on…
Read MoreSocial media approvals without going insane
A real life example, thank’s to Acquire.com 👇 Is there anything worse than thinking of a military-grade banger for the brand social account, only for it to get shot down by some C-suite who doesn’t understand social, after a painstaking 2-3 weeks of approvals and edits? Well, yeah. Lot’s of things. But it still sucks.…
Read MoreOpilio: Healthcare Data Liberation
Diving into the emerging healthcare data market and how Opilio wants to capture the long tail of provider organizations.
Read MoreWhat’s Up In Fintech
#1 Nasdaq Gets SEC Approval For First Exchange AI-Driven Order Type Nasdaq has just received the green light from the U.S. Securities and Exchange Commission (SEC) to launch an innovation in the world of stock trading: an AI-powered order type known as the Dynamic Midpoint Extended Life Order (M-ELO). This development provides an update on…
Read MoreA trillion-dollar carbon removal industry
Analyzing recent public sector funding for carbon removal in the U.S., its downstream and upstream impacts, and the path it paves for infrastructure deployment.
Read More